Use of X-Linked Clonal Analysis in Acute Promyelocytic Leukemia

References

• Seeker-Walker L. M. The meaning of a clone. Cancer Gen. Cytogen. 1985; 16: 87–88
   Google Scholar
• Wainscoat S., Fey M. F. Assessment of clonality in human tumors: a review. Cancer Res. 1990; 50: 1355–1360
   PubMed Web of Science ®Google Scholar
• Lyon M. F. The William Allan Memorial Award address: Chromosome inactivation and the location and expression of X-linked genes. Am. J. Hum. Gen. 1988; 42: 8–16
   PubMed Web of Science ®Google Scholar
• Fialkow P. J. Clonal origin of human tumours. Binchim. Biophys. Acta 1976; 458: 283–321
   PubMed Web of Science ®Google Scholar
• Beutler E., Collins Z., Irwin L. E. Value of genetic variants of Glucose-6-phosphate dehydrogenase in tracing the origin of malignant tumors. N. Eng. J. Meet. 1967; 276: 389–391
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Fearon E. R., Hamilton S. R., Pressinger A. C., Willard H. F., Michelson A. M., Riggs A. D., Orkin S. H. Clonal analysis using recombinant DNA probes from the chromosome. Cancer Res. 1987; 47: 4806–4813
   PubMed Web of Science ®Google Scholar
• Keith D. H., Singer-Sam J., Riggs A. D. Active chromosome DNA is unmethylated at eight CCGG sites clustered in a guanine plus cytosine rich island at the 5′ end of the gene for phosphoglycerate kinase. Mot. Cell Bio. 1986; 6: 4122–4125
   Web of Science ®Google Scholar
• Patel P. I., Framson P. E., Caskey C. T., Chinault A. C. Fine structure of the human hypoxanthine phosphoribosyl transferase gene. Mol. Cell Bio. 1986; 6: 393–403
   PubMed Web of Science ®Google Scholar
• Fraser N. J., Boyd Y., Brownlee G., Craig I. W. Multi-allelic RFLP for M27β an anonymous single copy genomic clone at Xp11.3-Xcen (HGM9 provisional No. DXS255). Nucleic Acids Res. 1987; 15: 9616
   PubMed Web of Science ®Google Scholar
• Abrahamson G., Fraser N. J., Boyd I., Craig 1., Wainscoat J. S. A highly informative X-chromosome probe, M27β can be used for the determination of tumour clonality. Br. J. Haematol. 1990; 74: 371–372
   PubMed Web of Science ®Google Scholar
• Hodges E., Howell W. M., Boyd Y., Smith J. L. Variable X-chromosome DNA methylation patterns detected with probe M27β in a series of lymphoid and myeloid malignancies. Br. J. Haematol. 1991; 77: 315–322
   PubMed Web of Science ®Google Scholar
• Gale R. E., Wheadon H., Linch D. C. Assessment of chromosome inactivation patterns using the hypervariable probe M27β in normal hemopoietic cells and acute myeloid leukaemic blasts. Leukaemia 1992; 6: 649–655
   PubMed Web of Science ®Google Scholar
• Gale R. E., Wheadon H., Goldstone A. H., Burnett A. K., Linch D. C. Frequency of clonal remission in acute myeloid leukaemia. Lancet 1993; 341: 138–142
   PubMed Web of Science ®Google Scholar
• Bennett J. B., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of Acute Myeloid Leukemia. Ann. Intern. Med. 1985; 103: 626–629
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Rowley J. D., Vardiman J. W., Testa J. R., Butler A. “Microgranular” acute promyelo-cytic leukemia: a distinct clinical, ultrastructural and cyto-genetic entity. Blood 1980; 55: 253–259
   PubMed Web of Science ®Google Scholar
• Larson R. A., Kondo K., Vardiman J. W., Butler A. E., Golomb H. M., Rowley J. D. Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia. Am. J. Med. 1984; 76: 827–841
   PubMed Web of Science ®Google Scholar
• De The H., Chomienne C., Lanotte M., Degos L., Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor—alpha gene to a novel transcribed locus. Nature 1990; 347: 558–561
   PubMed Web of Science ®Google Scholar
• Kakizuka A., Miller W. H., Jr, Umesono K., Warrell R. P., Jr, Frankel S. R., Murty V. V., Dmitrovsky E., Evans R. M. Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor PML. Cell 1991; 66: 663–674
   PubMed Web of Science ®Google Scholar
• Pandolfi P. P., Alcalay M., Fagioli M., Zangrilli D., Mencarelli A., Diverio D., Biondi A., Lo Coco F., Ram-baldi A., Grignani F., Rochette-Egly C, Gaube M.-P., Chambon P., Pelicci P. G. Genomic variability and alternative splicing generate multiple PML/RARa transcript that encode aberrant PML proteins and PML/RARa isofomis in acute promyelocytic leukemia. EMBOJ. 1992; 11: 1397–1407
   PubMed Web of Science ®Google Scholar
• Burrows J., Solomon E. Molecular analysis of the t(15;17) translocation in acute promyelocytic leukemia. Baillieres Clinical Haematology, B. D. Young. The Molecular Genetics of Haematological Malignancy. 1992; 833–856
   Google Scholar
• Biondi A., Rambaldi A., Alcalay M., Pandolfi P. P., Lo Coco F., Rossi V., Mencarelli A., Longo L., Zangrilli D., Mascra G., Barbui T., Mandelli F., Grignani F., Pelicci P. G. RAR-α Gene rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia. Blood 1991; 77: 1418–1422
   PubMed Web of Science ®Google Scholar
• Stone R. M., Mayer R. J. The unique aspects of acute promyelocytic leukemia. J. Clin. Oncol 1990; 8: 1913–1921
   PubMed Web of Science ®Google Scholar
• Stone R. M., Maguire M., Goldbert M. A., Antin J. H., Rosenthal D. S., Mayer R. J. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients. Blood 1988; 71: 690–696
   PubMed Web of Science ®Google Scholar
• Huang M. E., Ye U. C., Chai J. R., Lu J. X., Zhoa L., Gu L. J., Wang Z. Y. Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567–572
   PubMed Web of Science ®Google Scholar
• Castaigne S., Chomienne C., Daniel M. T., Ballerine P., Berger R., Fenaux P., Degos L. All trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia I clinical results. Blood 1990; 76: 1704–1709
   PubMed Web of Science ®Google Scholar
• Warrel R. M., Frankel S. R., Miller W. H., Scheirberg D. A., Hri L. M., Hittelman W. N., Vyas R., Andreef M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M. S., Dimitrovsky E. Differentiation therapy of acute promyelocyte leukemia with tretinoin (All trans retinoic acid). N. Eng. J. Med. 1991; 324: 1385–1393
   PubMed Web of Science ®Google Scholar
• White K. L., Wiley J. S., Frost T., McKenrick J. J., Hermann R. P., Seldon M., Enno A., Bell R., Bunce 1., Taylor K., Morgan M., Edwards L., Firkin F. C. All-trans retinoic acid in the treatment of acute promyelocytic leukemia. Aust. NZJ. Med. 1992; 22: 449–454
   PubMedGoogle Scholar
• Taylor K., Shetta M., Talpaz M., Kantarjian H., Hardikar S., Chinault A. C., McCredie K. B., Spitzer G. Myeloproliferative Disorder: Usefulness of X-linked Probes in Diagnosis. Leukemia 1989; 3: 419–422
   PubMed Web of Science ®Google Scholar
• Hoffman R., Silverstein M. N. Primary thrombocythemia. Hematology, Basic Principles and Practice, R. Hoffman, E. J. Benzdr, S. J. Shattil, B. Fume, H. J. Cohen. Churchill Livingstone, New York 1991; 881–889
   Google Scholar
• Wiernik P. H. Acute promyelocytic leukemia: another pseudoleukemia. Blood 1990; 76: 1675–1677
   PubMed Web of Science ®Google Scholar
• Fialkow P. S., Singer J. W., Raskind W. H., Adamson J. W., Jacobson R. H. J., Bernstein I. D., Dow L. W., Najfeld V., Veith R. Clonal development, stem cell differentiation and clinical remissions in acute non-lym-phocytic leukaemia. N. Eng. J. Med. 1987; 317: 468–473
   PubMed Web of Science ®Google Scholar
• Elliott S., Taylor K., White S., Rodwell R., Marlton P., Meagher D., Wiley J., Taylor D., Wright S., Timms P. Proof of differentiative mode of action of all trans retinoic acid in acute promyelocytic leukaemia using X-linked clonal analysis. Blood 1992; 79: 1916–1919
   PubMed Web of Science ®Google Scholar
• Ohashi H., Ichikawa A., Takagi N., Hotta T., Naoe T., Ohio R., Saito H. Remission induction of acute promyelocytic leukaemia by all-trans retinoic acid: Molecular evidence of restoration of normal hematopoiesis after differentiation and subsequent extinction of leukemic clone. Leukemia 1992; 6: 859–862
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Keating M. J., Walters R. J., Estey E. H., Mc Credie K. B., Smith T. L., Dalton W. T., Cork A., Trujillo J., Freireich E. J. Acute promyelocytic leukemia: The M.D. Anderson experience. Am. J. Med. 1986; 80: 789–797
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Burke P. J., Schiffer C. A., Zehnbauer B. A., Vogelstein B. Differentiation of leukaemia cells to polymorphonuclear leucocytes in patients with acute non-lymphocytic leukaemia. N. Eng. J. Med. 1986; 315: 15–24
   PubMed Web of Science ®Google Scholar
• Fialkow P. J., Janssen J. W. G., Bartram C. R. Clonal remissions in acute non-lymphocytic leukaemia: Evidence for a multistep pathogenesis of the Malignancy. Blood 1991; 77: 1415–1417
   PubMed Web of Science ®Google Scholar
• Bartram C. R., Ludwig W., Hiddemann W., Lyons J., Buschle M., Ritter J., Harbott J., Frohlich A., Janssen J. W. G. Acute Myeloid Leukaemia: Analysis of Ras gene mutations and clonality defined by Polymorphic X-linked loci. Leukaemia 1989; 3: 247–256
   PubMed Web of Science ®Google Scholar
• Taylor K., Hardikar S., Kantarjian H., Keating M., McCredie K., Chinault C., Spitzer G. Clonal expansion of granulopoiesis in Acute Myeloid Leukaemia in complete remission. Leukaemia 1987; 1: 277
   Web of Science ®Google Scholar
• Frankel S. R., Eardley A., Lauwers G., Weiss M., Warrell R. P., Jr. The “retinoic acid syndrome” in acute promyelocytic leukaemia. Ann. Intern. Med. 1992; 117: 292–296
   PubMed Web of Science ®Google Scholar
• Muindi J. R. F., Frankel S. R., Miller W. H., Jr, Jakubowski A., Scheinberg D. A., Young C. W., Dmitrovsky E., Warrell R. P., Jr. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: Implications for relapse and retinoid “resistance” in patients with acute promyelocytic leukaemia. Blood 1992; 79: 299–303
   PubMed Web of Science ®Google Scholar
• Smith M. A., Adamson P. C., Balis F. M., Feusner J., Aronson L., Murphy R. F., Horowitz M. E., Reaman G., Hammond G. D., Fenton R. M., Connaghan G. D., Hittelman W. N., Poplock D. G. Phase I and pharmacokinetic evaluation of all-trans retinoic acid in pediatric patients with cancer. J. Clin. Oncol. 1992; 10: 1666–1673
   PubMed Web of Science ®Google Scholar
• Miller W. H., Warrell R. P., De Blasio A., Levine K., Dimitrovsky E. An RT-PCR assay for the PMLRAR alpha mRNA can predict relapse and survival in acute promyelocytic leukaemia. Blood 1992; 80(Supp. 1)1019
   Google Scholar
• Chomienne C, Ballerini P., Balitraid N., Daniel M. T., Fenaux P., Castaigne S., Degas L. All trans retinoic acid in acute promyelocytic leukaemias II. In vitro studies: Structure-function relationship. Blood 1990; 76: 1710–1717
   PubMed Web of Science ®Google Scholar